PKCα also displays a role in other crucial changes of cancer cells, as observed in in vitro glioma models [73], where it promotes the cell proliferation and survival in response to anticancer treatments, via activation of the NF-κB pathway [74]. This evidence concerns the gene PRKCA and central nervous system cancer.